Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants

BACKGROUND: Very preterm infants are at risk of developing retinopathy of prematurity (ROP). Recombinant human erythropoietin (rhEPO) is routinely used to prevent anemia in preterm infants; however, the effect of rhEPO on ROP development is still controversial. The purpose of this study was to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Huiqing, Song, Juan, Kang, Wenqing, Wang, Yong, Sun, Xiantao, Zhou, Chongchen, Xiong, Hong, Xu, Falin, Li, Mingchao, Zhang, Xiaoli, Yu, Zengyuan, Peng, Xirui, Li, Bingbing, Xu, Yiran, Xing, Shan, Wang, Xiaoyang, Zhu, Changlian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574422/
https://www.ncbi.nlm.nih.gov/pubmed/33076939
http://dx.doi.org/10.1186/s12967-020-02562-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574422/
https://www.ncbi.nlm.nih.gov/pubmed/33076939
http://dx.doi.org/10.1186/s12967-020-02562-y

Ejemplares similares